Navigation Links
Blood Flow Measurement Boosts Stent Outcomes
Date:1/14/2009

Technology reduces deaths, complications, but may be too costly for some centers, experts say

WEDNESDAY, Jan. 14 (HealthDay News) -- A sophisticated measure of blood flow to determine where artery-opening stents should be implanted is more effective than the X-ray examinations now commonly used, an international study finds.

The technique, measuring what's known as "fractional flow reserve" (FFR), is designed for people who have multiple blockages that require artery-opening procedures such as angioplasty, followed by implantation of the flexible tubes called stents, explained study co-author Dr. Nico H. J. Pijls, professor of cardiology at the Catharina Hospital in Eindhoven, the Netherlands.

Such multiple blockages are seen in about 60 percent of cases, said Pijls, a leader in development of the flow-measuring technology.

The team published their findings in the Jan. 16 issue of the New England Journal of Medicine. The research was funded in part by Radi Medical Systems, which makes the FFR device tested in the trial.

The study, carried out in 20 European and U.S. medical centers, compared patient outcomes for stent implants using either FFR measurements or angiography (X-ray images) in 1,005 people who underwent artery-opening procedures.

Over a year of follow-up, 13.2 percent of those whose stents were implanted by the FFR method died, had major coronary events such as heart attacks or needed new procedures, compared to 18.3 percent of those in the X-ray group.

The cost of their treatment was lower, averaging $5,332 for the FFR cases against $6,007 for the angiography-guided group. The lower cost was due in part to the use of fewer stents in the FFR cases, an average of 1.9 versus 2.7 stents in the angiography group.

That's a real advantage, Pijls said, because, "you can do it in a more refined way. There are fewer complications, because instead of shooting for all stenoses [blockages], you can use stents only on those that are dangerous for the patient."

The FFR technology is not currently available in many medical centers, however. Its initial cost is $20,000, with a charge of about $600 for each use. "But its use will definitely increase if you look at these results, which I call impressive," Pijls said.

FFR is measured by inserting a pressure sensor mounted on a guidewire to the site of blockages in the arteries. FFR equipment is marketed by St. Jude Medical.

"This will provide impetus for some catheter laboratories to buy it, but we don't use it on a routine basis," said Dr. Stephen G. Ellis, director of the cardiac catheterization laboratory at the Cleveland Clinic and author of an editorial accompanying the report.

FFR measurements were used to guide stent implants in about 10 percent of cases at the Cleveland Clinic in the past year, Ellis said. "I doubt if we will be using it in more than 25 percent of cases," he said.

Cost is an issue, he said, since "economic times are hard for hospitals now. We don't have enough data on costs. What we need is a U.S.-based study of the cost involved. One would assume that because it reduces the number of second procedures, that would offset the roughly $600 cost per case."

The group that did the study "is now doing a more extended cost-benefit analysis," Pijls said.

The new report probably will not lead to a surge in American use of the FFR technology, according to Ellis, but its use is bound to widen. "This is not a revolution but a devolution," he said. "It is logical to treat only blockages that are physiologically significant."

More information

There's much more on stents at the U.S. Food and Drug Administration.



SOURCES: Nico H. J. Pijls, M.D., Ph.D., professor, cardiology, Catharina Hospital, Eindhoven, the Netherlands; Stephen G. Ellis, M.D., director, cardiac catheterization laboratory, Cleveland Clinic; Jan. 16, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Blood Emergency: Blood Supply Tips Into Danger Zone
2. University of Ottawa Heart Institute Scientists Successfully Develop Novel Biomaterial to Help Grow New Blood Vessels
3. Doctors Re-Examine Blood Thinners to Prevent Strokes
4. Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer
5. Penn researchers unlock molecular origin of blood stem cells
6. OHSU School of Dentistry team discovers new molecule in blood-pressure control system
7. Donate Blood Today -- Save Up to Three Lives
8. Viagra May Shield Heart From Blood Pressure Damage
9. Blood Drive Held in Honor of Gloucester City Resident - Evan Goldglantz
10. Young blood fights cancer
11. Rising Blood Sugar May Harm the Aging Brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Flow Measurement Boosts Stent Outcomes
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... While it’s ... poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , ... medication in darkness or restricted lighting. As such, it eliminates the need to turn ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: